The relationship between food security and ideal cardiovascular health while addressing disparities across minoritized groups.
Tislelizumab by BeiGene for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug